J. A. Faiella

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

Agnès Girard, D Girard, A. R. English et al. · Antimicrobial Agents and Chemotherapy · 1987 · 323 citations

Medicine, Pharmacokinetics, Pharmacology +14

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 238 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection

James A. Retsema, A. R. English, Agnès Girard et al. · Clinical Infectious Diseases · 1986 · 106 citations

Life Sciences, Microbiology, Pharmacology +17

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

Agnès Girard, D Girard, Thomas D. Gootz et al. · Antimicrobial Agents and Chemotherapy · 1995 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +12

Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection

Agnès Girard, C. R. Cimochowski, J. A. Faiella · Journal of Antimicrobial Chemotherapy · 1996 · 52 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +14